Loading...
XNAS
MLAB
Market cap428mUSD
Dec 05, Last price  
77.63USD
1D
0.62%
1Q
19.89%
Jan 2017
-36.76%
Name

Mesa Laboratories Inc

Chart & Performance

D1W1MN
XNAS:MLAB chart
P/E
P/S
1.78
EPS
Div Yield, %
0.62%
Shrs. gr., 5y
4.43%
Rev. gr., 5y
15.41%
Revenues
241m
+11.47%
11,583,00017,242,00019,558,00021,536,00021,929,00032,826,00039,616,00046,435,00052,724,00071,330,00084,659,00093,665,00096,179,000103,135,000117,687,000133,937,000184,335,000219,080,000216,187,000240,978,000
Net income
-2m
L-99.22%
2,805,0003,958,0004,610,0004,790,0004,769,0006,183,0007,919,0008,450,0009,000,0009,583,00011,169,00011,183,000-2,962,0007,484,0001,349,0003,274,0001,871,000930,000-254,246,000-1,974,000
CFO
47m
+6.06%
2,306,0004,032,0004,616,0005,075,0005,980,0008,873,00012,489,00011,402,00012,373,00010,816,00016,903,0007,750,00024,814,00030,554,00026,559,00037,073,00039,223,00027,983,00044,133,00046,808,000
Dividend
Nov 29, 20240 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in the United States, Europe, the Asia Pacific, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. Its Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enables to automate chemically synthesized peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The company's Calibration Solutions segment designs, manufactures, and markets quality control and calibration products to measure or calibrate temperature, pressure, pH, humidity, and other such parameters used for health and safety purposes in the hospital, medical device manufacturing, pharmaceutical manufacturing, and various laboratory and healthcare environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. Its Clinical Genomics segment develops, manufactures, and sells genetic analysis tools that include MassARRAY system and consumables, including chips, panels, and chemical reagent solutions used by clinical labs to perform genomic clinical testing in several therapeutic areas, such as newborn screenings, pharmacogenetics, and oncology. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.
IPO date
Feb 29, 1984
Employees
698
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT